ID   CRTDi001-A
AC   CVCL_Y543
AS   CVCL_IT58
SY   C1-1; T12.9; T12; MPIi004-A
DR   BioSamples; SAMEA104011275
DR   BioSamples; SAMEA104382077
DR   hPSCreg; CRTDi001-A
DR   SKIP; SKIP000294
DR   SKIP; SKIP002913
DR   Wikidata; Q54814517
RX   PubMed=23472874;
CC   From: Center for Regenerative Therapies Dresden (CRTD); Dresden; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54-56Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 11
//
RX   PubMed=23472874; DOI=10.1016/j.stem.2013.01.008;
RA   Reinhardt P., Schmid B., Burbulla L.F., Schondorf D.C., Wagner L.,
RA   Glatza M., Hoing S., Hargus G., Heck S.A., Dhingra A., Wu G.-M.,
RA   Muller S., Brockmann K., Kluba T., Maisel M., Kruger R., Berg D.,
RA   Tsytsyura Y., Thiel C.S., Psathaki O.E., Klingauf J., Kuhlmann T.,
RA   Klewin M., Muller H., Gasser T., Scholer H.R., Sterneckert J.;
RT   "Genetic correction of a LRRK2 mutation in human iPSCs links
RT   parkinsonian neurodegeneration to ERK-dependent changes in gene
RT   expression.";
RL   Cell Stem Cell 12:354-367(2013).
//